Limitations, agreements, and source contact

A Phase I/II Study of Ribociclib,a CDK4/6 Inhibitor, Following Radiation Therapy · Source last updated 2020-11-05

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement

pi Sponsor Employee

true

restrictive Agreement

false

point Of Contact

email

renee.doughman@cchmc.org

organization

Cincinnati Childrens Hosptial Medical Center

phone

513-636-1699

title

Renee Doughman

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice